Covestor LTD Pfizer Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Pfizer Inc stock. As of the latest transaction made, Covestor LTD holds 10,079 shares of PFE stock, worth $267,698. This represents 0.18% of its overall portfolio holdings.

Number of Shares

10,079

Previous 2,137 371.64%

Holding current value

$267,698

Previous $60,000 386.67%

% of portfolio

0.18%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $219,993 - $249,299	7,942 Added 371.64%	10,079 $292,000
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $153,378 - $179,731	-6,072 Reduced 73.97%	2,137 $60,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $24,129 - $27,708	-932 Reduced 10.2%	8,209 $228,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $18,500 - $24,029	-708 Reduced 7.19%	9,141 $263,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $15,659 - $18,304	-488 Reduced 4.72%	9,849 $326,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $5,706 - $6,602	158 Added 1.55%	10,337 $379,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $73,226 - $95,329	1,859 Added 22.34%	10,179 $415,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $64,211 - $83,821	1,538 Added 22.68%	8,320 $426,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $10,896 - $13,301	-249 Reduced 3.54%	6,782 $297,000
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $22,846 - $27,088	491 Added 7.51%	7,031 $368,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $139,446 - $172,791	3,048 Added 87.29%	6,540 $339,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $144,289 - $213,885	3,492 New	3,492 $206,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account